Literature DB >> 26507171

How important is the pathological margin distance in vulvar cancer?

G Baiocchi1, H Mantoan2, L de Brot3, L Badiglian-Filho2, L Y Kumagai2, C C Faloppa2, A A B A da Costa4.   

Abstract

PURPOSE: The ideal pathological margin in vulvar squamous cell carcinoma (VSCC) is still debated. Our aim was to analyze the value of tumor-free pathological margin distance with regard to local recurrence in VSCC.
METHODS: We analyzed a series of 205 patients who were treated for VSCC from January 1980 to November 2007. Patients were categorized into 3 groups, based on pathological free margin (PFM): <3 mm (n = 18); ≥3 and <8 mm (n = 61); and ≥8 mm (n = 126).
RESULTS: The median age was 69 years. The median PFM was 10 mm (range: 1-65). Of 168 patients who underwent lymphadenectomy, 64 (38.1%) developed LN metastasis. After a median follow-up of 36.2 months, 78 (38%) cases recurred-47 (60.2%) experienced a local recurrence (LR). LR occurred in 16.7% of patients with a PFM of <3 mm, 24.6% with a PFM ≥3 and <8 mm, and 22.2% of those with a PFM ≥8 mm (p = 0.77). PFM did not correlate with LR when analyzed continuously (p = 0.98). The 5-year disease-free survival (DFS) for LR was 79.6%. Margin distance did not negatively impact DFS (p = 0.94); the presence of perineural invasion was the only variable that negatively influenced DFS (p = 0.009).
CONCLUSIONS: Although our results suggest no correlation between LR and pathological margin distance, the tumor-free resection margin remains significant with regard to locoregional control in vulvar cancer. A more conservative surgical approach may be considered in certain situations, such as margins near the clitoris, urethra, and anus.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Margin distance; Prognosis; Recurrence; Vulvar cancer

Mesh:

Year:  2015        PMID: 26507171     DOI: 10.1016/j.ejso.2015.09.024

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  8 in total

1.  Role of adjuvant radiation or re-excision for early stage vulvar squamous cell carcinoma with positive or close surgical margins.

Authors:  Sabrina M Bedell; Chloe Hedberg; Anna Griffin; Hannah Pearson; Annelise Wilhite; Nathan Rubin; Britt K Erickson
Journal:  Gynecol Oncol       Date:  2019-06-03       Impact factor: 5.482

2.  Prognostic impact of reduced tumor-free margin distance on long-term survival in FIGO stage IB/II vulvar squamous cell carcinoma.

Authors:  Leonardo Micheletti; Mario Preti; Viviana Cintolesi; Elisabetta Corvetto; Silvana Privitera; Eleonora Palmese; Chiara Benedetto
Journal:  J Gynecol Oncol       Date:  2018-04-13       Impact factor: 4.401

3.  MRI evaluation of vulvar squamous-cell carcinoma in fresh radical local excision specimens for cancer localization and prediction of surgical tumor-free margins.

Authors:  Jan Heidkamp; Petra L M Zusterzeel; Adriana C H van Engen-van Grunsven; Christiaan G Overduin; Andor Veltien; Arie Maat; Maroeska M Rovers; Jurgen J Fütterer
Journal:  NMR Biomed       Date:  2018-11-15       Impact factor: 4.044

4.  Practical Guidance for Measuring and Reporting Surgical Margins in Vulvar Cancer.

Authors:  Kim E Kortekaas; Koen K Van de Vijver; Mariëtte I E van Poelgeest; C Blake Gilks; Vincent T H B M Smit; Saimah Arif; Deep Arora; Asma Faruqi; Raji Ganesan; Nicholas R Griffin; Richard Hale; Yelin E Hock; Lars-Christian Horn; W Glenn McCluggage; Pinias Mukonoweshuro; Kay J Park; Brian Rous; Bruce Tanchel; Anne-Sophie Van Rompuy; Gerry van Schalkwyk; Jo Vella; Marco Vergine; Naveena Singh; Tjalling Bosse
Journal:  Int J Gynecol Pathol       Date:  2020-09       Impact factor: 3.326

5.  Perineural Invasion in Vulvar Squamous-Cell Carcinoma Is an Independent Risk Factor for Cancer-Specific Survival, but Not for Locoregional Recurrence: Results from a Single Tertiary Referral Center.

Authors:  Leonardo Micheletti; Fulvio Borella; Mario Preti; Valentina Frau; Stefano Cosma; Sebastiana Privitera; Luca Bertero; Chiara Benedetto
Journal:  Cancers (Basel)       Date:  2021-12-28       Impact factor: 6.639

6.  An evaluation of prognostic factors, oncologic outcomes, and management for primary and recurrent squamous cell carcinoma of the vulva.

Authors:  Jessie Y Li; Christopher K Arkfeld; Joan Tymon-Rosario; Emily Webster; Peter Schwartz; Shari Damast; Gulden Menderes
Journal:  J Gynecol Oncol       Date:  2021-11-30       Impact factor: 4.756

Review 7.  Management of Early-Stage Vulvar Cancer.

Authors:  Priscila Grecca Pedrão; Yasmin Medeiros Guimarães; Luani Rezende Godoy; Júlio César Possati-Resende; Adriane Cristina Bovo; Carlos Eduardo Mattos Cunha Andrade; Adhemar Longatto-Filho; Ricardo Dos Reis
Journal:  Cancers (Basel)       Date:  2022-08-29       Impact factor: 6.575

8.  Assessment of TSPAN Expression Profile and Their Role in the VSCC Prognosis.

Authors:  Kelly Pedrozo Ferreira; Bruna Cristine de Almeida; Laura Gonzalez Dos Anjos; Glauco Baiocchi; Fernando Augusto Soares; Rafael Malagoli Rocha; Edmund Chada Baracat; Andrey Senos Dobroff; Katia Candido Carvalho
Journal:  Int J Mol Sci       Date:  2021-05-09       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.